These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 24459779)

  • 41. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 42. FDA inspections find unsafe practices in compounding pharmacies.
    McCarthy M
    BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476
    [No Abstract]   [Full Text] [Related]  

  • 43. Distinguishing between compounding facilities and the development of the 503B bulk drug substance list.
    Gianturco SL; Mattingly AN
    J Am Pharm Assoc (2003); 2021; 61(1):e8-e11. PubMed ID: 32713748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.
    Quertermous J; Desai S; Harper J; Lebwohl M; Torres A; Kircik LH
    J Drugs Dermatol; 2018 Jul; 17(7):s17-s22. PubMed ID: 30005109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. U.S. Food and Drug Administration requests for input on HR 3204 enactment: the Drug Quality and Security Act of 2013.
    Miller DG
    Int J Pharm Compd; 2014; 18(1):35-6. PubMed ID: 24881338
    [No Abstract]   [Full Text] [Related]  

  • 46. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 47. International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Food and Drug Administration's Misguided Veterinary Guidance.
    Miller DG
    Int J Pharm Compd; 2015; 19(6):449-50. PubMed ID: 26891558
    [No Abstract]   [Full Text] [Related]  

  • 48. Application of the Food and Drug Administration's current good manufacturing practices regulations to pharmacy practice: a legal view.
    Fink JL
    Contemp Pharm Pract; 1979; 2(4):202-5. PubMed ID: 10244540
    [No Abstract]   [Full Text] [Related]  

  • 49. Legal cognitive requirements impact on pharmacy practice and patient outcomes.
    Svensberg K; Björnsdottir I; Kälvemark Sporrong S
    Res Social Adm Pharm; 2015; 11(4):590-1. PubMed ID: 25703896
    [No Abstract]   [Full Text] [Related]  

  • 50. Protecting consumers from counterfeit drugs.
    FDA Consum; 2004; 38(3):12-3. PubMed ID: 15218838
    [No Abstract]   [Full Text] [Related]  

  • 51. Déjà vu all over again!
    Allen LV
    Int J Pharm Compd; 2014; 18(3):180. PubMed ID: 25306763
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacists' liability: what my pharmacy law professor did not cover.
    Rizo M; Seamon M
    Int J Pharm Compd; 2013; 17(4):290-3. PubMed ID: 24261143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preventing medication errors with nimodipine by compounding proper dosage forms.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(5):364-8. PubMed ID: 24459780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IACP's 2016 Compounders on Capitol Hill Asks.
    Int J Pharm Compd; 2016; 20(4):294-296. PubMed ID: 28333674
    [No Abstract]   [Full Text] [Related]  

  • 55. [Norms for providing the Czechoslovak medical service with pharmaceuticals. 3. Preparation of galenic preparations in pharmacies].
    Solich J; Dofková L; Ajgelová J
    Cesk Farm; 1968 Sep; 17(7):342-8. PubMed ID: 5679399
    [No Abstract]   [Full Text] [Related]  

  • 56. Drugs: just a click away. Online pharmacies can make dangerous drugs easy to get, but also can promote better health care. Should we regulate them?
    Brand R
    State Legis; 2007 Jun; 33(6):45, 47, 49. PubMed ID: 17546803
    [No Abstract]   [Full Text] [Related]  

  • 57. Federal court strikes down compounding regulations.
    Harteker LR
    Am J Health Syst Pharm; 2001 Apr; 58(8):638, 640, 643. PubMed ID: 11329752
    [No Abstract]   [Full Text] [Related]  

  • 58. Warranties of a compounding pharmacist.
    Brushwood DB; Smith WT
    Am J Health Syst Pharm; 2009 Mar; 66(5):495-8. PubMed ID: 19233998
    [No Abstract]   [Full Text] [Related]  

  • 59. The International Academy of Compounding Pharmacists stepping up efforts to remedy problems caused by the U.S. Drug Enforcement Administration's "constructive transfer" policy.
    Miller DG
    Int J Pharm Compd; 2012; 16(2):94-6. PubMed ID: 23050319
    [No Abstract]   [Full Text] [Related]  

  • 60. The Third Policy Arena: Standard-Setting Organizations.
    Consult Pharm; 2016 Mar; 31(3):176. PubMed ID: 26975597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.